333 related articles for article (PubMed ID: 18836203)
1. HER-2 protein overexpression in metastatic breast carcinoma found at autopsy.
Kyoda S; Kinoshita S; Takeyama H; Uchida K; Morikawa T
Jpn J Clin Oncol; 2008 Nov; 38(11):743-7. PubMed ID: 18836203
[TBL] [Abstract][Full Text] [Related]
2. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
Vincent-Salomon A; Jouve M; Genin P; Fréneaux P; Sigal-Zafrani B; Caly M; Beuzeboc P; Pouillart P; Sastre-Garau X
Cancer; 2002 Apr; 94(8):2169-73. PubMed ID: 12001113
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.
Guarneri V; Giovannelli S; Ficarra G; Bettelli S; Maiorana A; Piacentini F; Barbieri E; Dieci MV; D'Amico R; Jovic G; Conte P
Oncologist; 2008 Aug; 13(8):838-44. PubMed ID: 18650259
[TBL] [Abstract][Full Text] [Related]
4. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
[TBL] [Abstract][Full Text] [Related]
5. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.
Forseen SE; Potti A; Koka V; Koch M; Fraiman G; Levitt R
Anticancer Res; 2002; 22(3):1599-602. PubMed ID: 12168843
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
7. [Visceral metastasis in 135 cases of breast cancer: evaluation at autopsy].
Nakamura T; Sakamoto G; Kitagawa T; Kasuga T; Sugano H
Gan No Rinsho; 1983 Dec; 29(15):1717-20. PubMed ID: 6668670
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease.
Sauer T; Pedersen MK; Ebeltoft K; Naess O
Cytopathology; 2005 Aug; 16(4):193-8. PubMed ID: 16048505
[TBL] [Abstract][Full Text] [Related]
9. Metastatic patterns in adenocarcinoma.
Hess KR; Varadhachary GR; Taylor SH; Wei W; Raber MN; Lenzi R; Abbruzzese JL
Cancer; 2006 Apr; 106(7):1624-33. PubMed ID: 16518827
[TBL] [Abstract][Full Text] [Related]
10. [primary and secondary malignant liver tumors at autopsy, biopsy and cytology: frequency and problems of differential diagnosis].
Nizze H; Hebecker R; Stropahl G; Putzke HP; Barten M; Käckenmeister A
Verh Dtsch Ges Pathol; 1995; 79():137-43. PubMed ID: 8600678
[TBL] [Abstract][Full Text] [Related]
11. [The metastatic pattern of malignant tumors].
Liu FS; Yang HY; Sui GJ
Zhonghua Yi Xue Za Zhi; 1994 Jul; 74(7):406-9, 454. PubMed ID: 7987711
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic brain tumor in the elderly].
Kawahata N; Ohtomo E
Rinsho Shinkeigaku; 1989 Sep; 29(9):1106-9. PubMed ID: 2598535
[TBL] [Abstract][Full Text] [Related]
13. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ
Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366
[TBL] [Abstract][Full Text] [Related]
14. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Jung YY; Kim HM; Koo JS
PLoS One; 2015; 10(9):e0137204. PubMed ID: 26334757
[TBL] [Abstract][Full Text] [Related]
15. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases as late breast cancer relapse. Single institution experience and review of the literature.
Tomasevic Z; Radosevic-Jelic Lj; Jovanovic D; Milovanovic Z; Tomasevic ZM; Jelic S; Borojevic N
J BUON; 2009; 14(2):225-8. PubMed ID: 19650170
[TBL] [Abstract][Full Text] [Related]
17. [Postoperative brain metastasis from esophageal carcinomas: report of 4 cases].
Kaneko T; Hirao M; Shimada M; Takayama T; Iwazawa T; Murata K; Inoue M; Terashima T; Mizunoya S; Okagawa K
Kyobu Geka; 1991 Nov; 44(12):1013-7. PubMed ID: 1758102
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of lung cancer metastases. I. Combination and frequency of organ metastases].
Barz H; Barz D; Klemm P
Arch Geschwulstforsch; 1982; 52(7):551-60. PubMed ID: 7165490
[TBL] [Abstract][Full Text] [Related]
19. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
[TBL] [Abstract][Full Text] [Related]
20. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
